BioNTech Income Before Tax from 2010 to 2024

0A3M Stock  USD 110.25  4.06  3.55%   
BioNTech Income Before Tax yearly trend continues to be quite stable with very little volatility. The value of Income Before Tax is projected to decrease to about 1.1 B. From the period between 2010 and 2024, BioNTech, Income Before Tax regression line of its data series had sample variance of 24193109.1 T and sample variance of 24193109.1 T. View All Fundamentals
 
Income Before Tax  
First Reported
2010-12-31
Previous Quarter
1.2 B
Current Value
1.1 B
Quarterly Volatility
4.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Other Operating Expenses of 385.3 M or EBIT of 14.4 B, as well as many indicators such as . BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
This module can also supplement various BioNTech Technical models . Check out the analysis of BioNTech Correlation against competitors.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:
Check out the analysis of BioNTech Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.